IOL CHEMICALS & PHARM. | ALEMBIC PHARMA | IOL CHEMICALS & PHARM./ ALEMBIC PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 31.2 | 44.0% | View Chart |
P/BV | x | 1.6 | 4.3 | 36.5% | View Chart |
Dividend Yield | % | 1.0 | 0.8 | 118.5% |
IOL CHEMICALS & PHARM. ALEMBIC PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ALEMBIC PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ ALEMBIC PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 792 | 67.7% | |
Low | Rs | 272 | 463 | 58.8% | |
Sales per share (Unadj.) | Rs | 377.6 | 287.6 | 131.3% | |
Earnings per share (Unadj.) | Rs | 23.7 | 17.4 | 136.2% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 31.4 | 100.5% | |
Dividends per share (Unadj.) | Rs | 4.00 | 8.00 | 50.0% | |
Avg Dividend yield | % | 1.0 | 1.3 | 77.6% | |
Book value per share (Unadj.) | Rs | 256.8 | 222.3 | 115.5% | |
Shares outstanding (eoy) | m | 58.71 | 196.56 | 29.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.2 | 49.1% | |
Avg P/E ratio | x | 17.1 | 36.1 | 47.3% | |
P/CF ratio (eoy) | x | 12.8 | 20.0 | 64.1% | |
Price / Book Value ratio | x | 1.6 | 2.8 | 55.8% | |
Dividend payout | % | 16.9 | 46.0 | 36.7% | |
Avg Mkt Cap | Rs m | 23,743 | 123,402 | 19.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 11,691 | 14.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 56,526 | 39.2% | |
Other income | Rs m | 256 | 30 | 842.4% | |
Total revenues | Rs m | 22,427 | 56,557 | 39.7% | |
Gross profit | Rs m | 2,257 | 6,772 | 33.3% | |
Depreciation | Rs m | 462 | 2,754 | 16.8% | |
Interest | Rs m | 165 | 502 | 32.8% | |
Profit before tax | Rs m | 1,887 | 3,546 | 53.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 126 | 392.6% | |
Profit after tax | Rs m | 1,391 | 3,420 | 40.7% | |
Gross profit margin | % | 10.2 | 12.0 | 85.0% | |
Effective tax rate | % | 26.2 | 3.6 | 738.0% | |
Net profit margin | % | 6.3 | 6.1 | 103.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 29,139 | 33.2% | |
Current liabilities | Rs m | 5,025 | 16,408 | 30.6% | |
Net working cap to sales | % | 20.9 | 22.5 | 92.9% | |
Current ratio | x | 1.9 | 1.8 | 108.3% | |
Inventory Days | Days | 43 | 10 | 446.6% | |
Debtors Days | Days | 8 | 7 | 123.1% | |
Net fixed assets | Rs m | 11,017 | 31,498 | 35.0% | |
Share capital | Rs m | 587 | 393 | 149.4% | |
"Free" reserves | Rs m | 14,490 | 43,312 | 33.5% | |
Net worth | Rs m | 15,077 | 43,705 | 34.5% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 60,637 | 34.1% | |
Interest coverage | x | 12.5 | 8.1 | 154.4% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.9 | 115.0% | |
Return on assets | % | 7.5 | 6.5 | 116.3% | |
Return on equity | % | 9.2 | 7.8 | 117.9% | |
Return on capital | % | 13.6 | 9.3 | 146.9% | |
Exports to sales | % | 26.7 | 46.4 | 57.7% | |
Imports to sales | % | 0 | 12.1 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 26,210 | 22.6% | |
Imports (cif) | Rs m | NA | 6,846 | 0.0% | |
Fx inflow | Rs m | 5,930 | 26,210 | 22.6% | |
Fx outflow | Rs m | 6,052 | 6,846 | 88.4% | |
Net fx | Rs m | -122 | 19,364 | -0.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 7,240 | 16.9% | |
From Investments | Rs m | -1,200 | -4,476 | 26.8% | |
From Financial Activity | Rs m | -41 | -2,620 | 1.6% | |
Net Cashflow | Rs m | -18 | 144 | -12.8% |
Indian Promoters | % | 48.2 | 69.1 | 69.7% | |
Foreign collaborators | % | 0.0 | 0.5 | - | |
Indian inst/Mut Fund | % | 1.7 | 19.8 | 8.6% | |
FIIs | % | 1.4 | 4.5 | 31.4% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 30.4 | 170.5% | |
Shareholders | 130,003 | 76,567 | 169.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | ALEMBIC PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.40% | 1.26% | 1.03% |
1-Month | 6.23% | -1.22% | 1.10% |
1-Year | 1.15% | 74.61% | 53.75% |
3-Year CAGR | -12.75% | -1.67% | 14.67% |
5-Year CAGR | 16.32% | 12.40% | 19.26% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the ALEMBIC PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of ALEMBIC PHARMA the stake stands at 69.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of ALEMBIC PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
ALEMBIC PHARMA paid Rs 8.0, and its dividend payout ratio stood at 46.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of ALEMBIC PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.